XML 21 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Operating Segments and Related Information
9 Months Ended
Sep. 30, 2018
Segment Reporting [Abstract]  
Operating Segments and Related Information
Operating Segments and Related Information
The Company conducts its operations through the following three reportable segments:
Recovery Audit Services – Americas represents recovery audit services (other than Healthcare Claims Recovery Audit services) provided in the United States of America (“U.S.”), Canada and Latin America.
Recovery Audit Services – Europe/Asia-Pacific represents recovery audit services (other than Healthcare Claims Recovery Audit services) provided in Europe, Asia and the Pacific region.
Adjacent Services represents data transformation, spend analytics, PRGX OPTIX®, supplier information management ("SIM") services and associated advisory services.
Additionally, Corporate Support includes the unallocated portion of corporate selling, general and administrative expenses not specifically attributable to the three reportable segments.
During the fourth quarter of 2015, PRGX entered into agreements with third parties to fulfill its Medicare recovery audit contractor ("RAC") program subcontract obligations to audit Medicare payments and provide support for claims appeals and assigned its remaining Medicaid contract to another party. Revenue is recognized from historical claims when performance obligations are satisfied. The Company will continue to incur certain expenses and may realize additional revenue until the wind-down of this business is complete. As a result, the Healthcare Claims Recovery Audit services business has been reported as Discontinued Operations in accordance with GAAP.
The following table presents the discontinued operations of the Healthcare Claims Recovery Audit services business in the Consolidated Statement of Operations, for the three and nine months ended September 30, 2018 and 2017 (in thousands):
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
2018
 
2017
 
2018
 
2017
Revenue, net of refund liabilities
$

 
$

 
$
157

 
$

Cost of sales
319

 
337

 
831

 
1,013

Selling, general and administrative expense
6

 
5

 
9

 
10

Depreciation and amortization

 
2

 
1

 
6

Loss from discontinued operations before income taxes
$
(325
)
 
$
(344
)
 
$
(684
)
 
$
(1,029
)
Income tax expense

 

 

 

Net loss from discontinued operations
$
(325
)
 
$
(344
)
 
$
(684
)
 
$
(1,029
)


The following table presents the discontinued operations of the Healthcare Claims Recovery Audit services business in the Consolidated Statements of Cash Flows, for the nine months ended September 30, 2018 and 2017 (in thousands):
 
Nine Months Ended September 30,
 
2018
 
2017
Net cash used in operating activities
$
(684
)

$
(1,023
)
Net cash used in investing activities



Net cash provided by financing activities



Decrease in cash and cash equivalents
$
(684
)

$
(1,023
)

The Company evaluates the performance of its reportable segments based upon revenue and measures of profit or loss referred to as EBITDA and Adjusted EBITDA. The Company defines Adjusted EBITDA as earnings from continuing operations before interest and taxes (“EBIT”), adjusted for depreciation and amortization (“EBITDA”), and then further adjusted for unusual and other significant items that management views as distorting the operating results of the various segments from period to period. Such adjustments include restructuring charges, stock-based compensation, bargain purchase gains, acquisition-related charges and benefits (acquisition transaction costs, acquisition obligations classified as compensation, and fair value adjustments to acquisition-related contingent consideration), tangible and intangible asset impairment charges, certain litigation costs and litigation settlements, certain severance charges and foreign currency transaction gains and losses on short-term intercompany balances viewed by management as individually or collectively significant. The Company does not have any inter-segment revenue.
Segment information for the three and nine months ended September 30, 2018 and 2017 (in thousands) is as follows:
 
 
 
Recovery
Audit
Services –
Americas
 
Recovery Audit
Services –
Europe/Asia-
Pacific
 
Adjacent
Services
 
Corporate
Support
 
Total
Three Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
Revenue, net of refund liabilities
 
$
28,806

 
$
12,191

 
$
2,323

 
$

 
$
43,320

Net income from continuing operations
 
 
 
 
 
 
 
 
 
2,626

Income tax expense
 
 
 
 
 
 
 
 
 
597

Interest expense, net
 
 
 
 
 
 
 
 
 
416

EBIT
 
$
6,522

 
$
2,585


$
(847
)

$
(4,621
)
 
$
3,639

Depreciation of property and equipment
 
1,260

 
164

 
289

 

 
1,713

Amortization of intangible assets
 
445

 
37

 
390

 

 
872

EBITDA
 
$
8,227

 
$
2,786

 
$
(168
)
 
$
(4,621
)
 
$
6,224

Other (income) loss
 
(3
)
 
61

 

 
(59
)
 
(1
)
Foreign currency transaction (gains) losses on short-term intercompany balances
 
(78
)
 
177

 
10

 
(39
)
 
70

Transformation severance and related expenses
 
179

 
(16
)
 
(2
)
 
278

 
439

Acquisition-related adjustment (income) loss
 





 
(1,640
)
 
(1,640
)
Stock-based compensation
 

 

 

 
1,341

 
1,341

Adjusted EBITDA
 
$
8,325

 
$
3,008

 
$
(160
)
 
$
(4,740
)
 
$
6,433


 
 
Recovery
Audit
Services –
Americas
 
Recovery Audit
Services –
Europe/Asia-
Pacific
 
Adjacent
Services
 
Corporate
Support
 
Total
Three Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
Revenue, net of refund liabilities
 
$
30,705

 
$
10,837

 
$
925

 
$

 
$
42,467

Net income from continuing operations
 
 
 
 
 
 
 
 
 
1,077

Income tax expense
 
 
 
 
 
 
 
 
 
930

Interest expense, net
 
 
 
 
 
 
 
 
 
142

EBIT
 
$
8,539

 
$
2,289

 
$
(2,026
)
 
$
(6,653
)
 
$
2,149

Depreciation of property and equipment
 
789

 
161

 
183

 

 
1,133

Amortization of intangible assets
 
329

 

 
393

 

 
722

EBITDA
 
$
9,657

 
$
2,450

 
$
(1,450
)
 
$
(6,653
)
 
$
4,004

Other (income) loss
 
(11
)
 

 
(2
)
 
30

 
17

Foreign currency transaction (gains) losses on short-term intercompany balances
 
(155
)
 
(377
)
 
(6
)
 
120

 
(418
)
Transformation severance and related expenses
 
49

 
360

 
260

 
23

 
692

Stock-based compensation
 

 

 

 
2,107

 
2,107

Adjusted EBITDA
 
$
9,540

 
$
2,433

 
$
(1,198
)
 
$
(4,373
)
 
$
6,402


 
 
Recovery
Audit
Services –
Americas
 
Recovery Audit
Services –
Europe/Asia-
Pacific
 
Adjacent
Services
 
Corporate
Support
 
Total
Nine Months Ended September 30, 2018
 
 
 
 
 
 
 
 
 
 
Revenue, net of refund liabilities
 
$
83,676


$
33,663


$
4,804

 
$

 
$
122,143

Net loss from continuing operations
 
 
 
 
 
 
 
 
 
(2,582
)
Income tax expense
 
 
 
 
 
 
 
 
 
1,573

Interest expense, net
 
 
 
 
 
 
 
 
 
1,300

EBIT
 
$
16,845


$
5,802


$
(3,626
)
 
$
(18,730
)
 
$
291

Depreciation of property and equipment
 
3,876


512


908

 

 
5,296

Amortization of intangible assets
 
1,218


136


1,170

 

 
2,524

EBITDA
 
$
21,939

 
$
6,450

 
$
(1,548
)
 
$
(18,730
)
 
$
8,111

Other (income) loss
 
(3
)

166



 
(147
)
 
16

Foreign currency transaction losses (gains) on short-term intercompany balances
 
128


853


14

 
(265
)
 
730

Transformation severance and related expenses
 
728


999


66

 
635

 
2,428

Acquisition-related adjustment (income) loss
 





 
(1,640
)
 
(1,640
)
Stock-based compensation
 





 
4,159

 
4,159

Adjusted EBITDA
 
$
22,792

 
$
8,468

 
$
(1,468
)
 
$
(15,988
)
 
$
13,804


 
 
Recovery
Audit
Services –
Americas
 
Recovery Audit
Services –
Europe/Asia-
Pacific
 
Adjacent
Services
 
Corporate
Support
 
Total
Nine Months Ended September 30, 2017
 
 
 
 
 
 
 
 
 
 
Revenue, net of refund liabilities
 
$
81,641

 
$
29,441

 
$
3,464

 
$

 
$
114,546

Net loss from continuing operations
 
 
 
 
 
 
 
 
 
(1,096
)
Income tax expense
 
 
 
 
 
 
 
 
 
2,436

Interest expense, net
 
 
 
 
 
 
 
 
 
227

EBIT
 
$
20,110

 
$
5,754

 
$
(5,681
)
 
$
(18,616
)
 
$
1,567

Depreciation of property and equipment
 
2,478

 
453

 
531

 

 
3,462

Amortization of intangible assets
 
986

 

 
1,180

 

 
2,166

EBITDA
 
$
23,574

 
$
6,207

 
$
(3,970
)
 
$
(18,616
)
 
$
7,195

Other (income) loss
 
(11
)
 

 
(195
)
 
29

 
(177
)
Foreign currency transaction (gains) losses on short-term intercompany balances
 
(396
)
 
(1,566
)
 
(10
)
 
45

 
(1,927
)
Transformation severance and related expenses
 
313

 
582

 
305

 
392

 
1,592

Stock-based compensation
 

 

 

 
5,362

 
5,362

Adjusted EBITDA
 
$
23,480

 
$
5,223

 
$
(3,870
)
 
$
(12,788
)
 
$
12,045